Cargando…
Fe(3)O(4) magnetic nanoparticle-enhanced radiotherapy for lung adenocarcinoma via delivery of siBIRC5 and AS-ODN
BACKGROUND: Radiotherapy is the mainstay treatment for lung adenocarcinoma, yet remains highly susceptible to resistance. Fe(3)O(4) magnetic nanoparticles (MNPs) possess the ability to induce biological therapeutic effects. Herein, the current study set out to explore the effects of Fe(3)O(4) MNPs o...
Autores principales: | Chen, Shuzhen, Han, Fushi, Huang, Dongdong, Meng, Jinqian, Chu, Jiapeng, Wang, Meng, Wang, Peijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351328/ https://www.ncbi.nlm.nih.gov/pubmed/34372869 http://dx.doi.org/10.1186/s12967-021-02971-7 |
Ejemplares similares
-
miR‐126‐5p enhances radiosensitivity of lung adenocarcinoma cells by inhibiting EZH2 via the KLF2/BIRC axis
por: Han, Fushi, et al.
Publicado: (2022) -
Silencing of lncRNA LINC00857 Enhances BIRC5-Dependent Radio-Sensitivity of Lung Adenocarcinoma Cells by Recruiting NF-κB1
por: Han, Fushi, et al.
Publicado: (2020) -
Retraction Notice to: Silencing of lncRNA LINC00857 Enhances BIRC5-Dependent Radio-Sensitivity of Lung Adenocarcinoma Cells by Recruiting NF-κB1
por: Han, Fushi, et al.
Publicado: (2022) -
Exosomal microRNA‐26b‐5p down‐regulates ATF2 to enhance radiosensitivity of lung adenocarcinoma cells
por: Han, Fushi, et al.
Publicado: (2020) -
BIRC3 and BIRC5: multi‐faceted inhibitors in cancer
por: Frazzi, Raffaele
Publicado: (2021)